What is the choice of antibiotic for Group B Streptococcus (GBS) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Choice for Group B Streptococcus (GBS) in Pregnancy

For Group B Streptococcus in pregnancy, intravenous penicillin G (5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery) is the first-line antibiotic of choice, with ampicillin as an acceptable alternative. 1, 2

First-Line Treatment Options

For non-penicillin allergic patients:

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery 1, 2
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery (alternative) 1, 2

Management Algorithm for Penicillin-Allergic Patients

For patients with penicillin allergy, treatment depends on the risk of anaphylaxis:

Low Risk for Anaphylaxis (no history of anaphylaxis, angioedema, respiratory distress, or urticaria):

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery 1, 2

High Risk for Anaphylaxis:

  1. If GBS isolate is tested and susceptible to clindamycin and erythromycin:

    • Clindamycin: 900 mg IV every 8 hours until delivery 1
  2. If GBS isolate is resistant to erythromycin but susceptible to clindamycin:

    • Clindamycin can be used if testing for inducible clindamycin resistance is negative 1
  3. If GBS isolate is resistant to clindamycin, shows inducible resistance, or susceptibility is unknown:

    • Vancomycin: 1 g IV every 12 hours until delivery 1, 2

Important Clinical Considerations

  • Susceptibility testing is essential for penicillin-allergic patients due to increasing resistance to alternative antibiotics 2
  • Erythromycin is no longer recommended for GBS prophylaxis due to increasing resistance and poor placental transfer 2
  • Intrapartum antibiotics should ideally be administered at least 4 hours before delivery for maximum effectiveness 1, 2, 3
  • Oral antibiotics during pregnancy are not effective for eliminating GBS colonization or preventing neonatal disease 2

Indications for Intrapartum Antibiotic Prophylaxis

Antibiotics should be administered to women with:

  • Positive GBS vaginal-rectal screening culture in current pregnancy
  • GBS bacteriuria during any trimester of current pregnancy
  • Previous infant with invasive GBS disease
  • Unknown GBS status at labor onset with risk factors (preterm delivery, rupture of membranes >18 hours, or intrapartum fever) 2, 4

Potential Pitfalls and Caveats

  • Failure to perform susceptibility testing in penicillin-allergic patients may lead to inappropriate antibiotic selection and treatment failure 2
  • Administering antibiotics less than 4 hours before delivery reduces effectiveness, though antibiotics should still be initiated as soon as possible 2, 3
  • The risk of anaphylaxis with penicillin is estimated at about 5 cases per 10,000 treatments, which can have severe consequences for both mother and child 5
  • Treating GBS colonization with oral antibiotics in the third trimester is ineffective, as 30-70% of treated women remain colonized at delivery 2

By following this evidence-based approach to antibiotic selection for GBS in pregnancy, clinicians can significantly reduce the risk of early-onset neonatal GBS infections by as much as 80-95% 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Asymptomatic Group B Streptococcus Bacteriuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Group B Streptococcus in Pregnancy.

Obstetrics and gynecology clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.